Clinical profile of patients treated with cefepime/tazobactam: A new ß-lactam/ß-lactamase inhibitor combination
Objectives: Cefepime/tazobactam is a new ß-lactam/ß-lactamase inhibitor combination licensed for clinical use byDrugs Controller General of India. Aim of our study was to analyze the clinical efficacy and safety of cefepime/tazobactamin patients with sepsis. To the best of our knowledge, this is the...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Eldaghayes Publisher
2012-06-01
|
| Serie: | Journal of Microbiology and Infectious Diseases |
| Soggetti: | |
| Accesso online: | http://www.jcmid.org/upload/sayi/9/JMID-00583.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|